Kerger J - Search Results

1

Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients.

de Wit R, Kruit WH, Stoter G, de Boer M, Kerger J, Verweij J. de Wit R, et al. Among authors: kerger j. Br J Cancer. 1998 Nov;78(10):1342-5. doi: 10.1038/bjc.1998.681. Br J Cancer. 1998. PMID: 9823976 Free PMC article. Clinical Trial.

2

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials Group.

Aamdal S, Wolff I, Kaplan S, Paridaens R, Kerger J, Schachter J, Wanders J, Franklin HR, Verweij J. Aamdal S, et al. Among authors: kerger j. Eur J Cancer. 1994;30A(8):1061-4. doi: 10.1016/0959-8049(94)90456-1. Eur J Cancer. 1994. PMID: 7654429 Clinical Trial.

3

Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

van Hoesel QG, Verweij J, Catimel G, Clavel M, Kerbrat P, van Oosterom AT, Kerger J, Tursz T, van Glabbeke M, van Pottelsberghe C, et al. van Hoesel QG, et al. Among authors: kerger j. Ann Oncol. 1994 Jul;5(6):539-42. doi: 10.1093/oxfordjournals.annonc.a058909. Ann Oncol. 1994. PMID: 7918126 Free article. Clinical Trial.

4

Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group.

Verweij J, de Mulder PH, de Graeff A, Vermorken JB, Wildiers J, Kerger J, Schornagel J, Cognetti F, Kirkpatrick A, Sahmoud T, Lefebvre JL. Verweij J, et al. Among authors: kerger j. Ann Oncol. 1996 Oct;7(8):867-9. doi: 10.1093/oxfordjournals.annonc.a010770. Ann Oncol. 1996. PMID: 8922205 Free article. Clinical Trial.

5

Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicity.

Aamdal S, Bruntsch U, Kerger J, Verweij J, ten Bokkel Huinink W, Wanders J, Rastogi R, Franklin HR, Kaye SB. Aamdal S, et al. Among authors: kerger j. Cancer Chemother Pharmacol. 1997;40(5):439-43. doi: 10.1007/s002800050683. Cancer Chemother Pharmacol. 1997. PMID: 9272122 Clinical Trial.

6

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.

Awada A, Punt CJ, Piccart MJ, Van Tellingen O, Van Manen L, Kerger J, Groot Y, Wanders J, Verweij J, Wagener DJ. Awada A, et al. Among authors: kerger j. Br J Cancer. 1999 Mar;79(9-10):1454-61. doi: 10.1038/sj.bjc.6690232. Br J Cancer. 1999. PMID: 10188890 Free PMC article. Clinical Trial.

7

A phase I and pharmacokinetic study of docetaxel administered in combination with continuous intravenous infusion of 5-fluorouracil in patients with advanced solid tumors.

Van Den Neste E, de Valeriola D, Kerger J, Bleiberg H, Kusenda Z, Brassinne C, Bartholomeus S, Selleslags J, Hennebert P, Wythouck H, Cazenave I, Lefresne-Soulas F, Piccart M. Van Den Neste E, et al. Among authors: kerger j. Clin Cancer Res. 2000 Jan;6(1):64-71. Clin Cancer Res. 2000. PMID: 10656433 Clinical Trial.

8

Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.

Freyer G, Hennebert P, Awada A, Gil T, Kerger J, Selleslags J, Brassinne C, Piccart M, de Valeriola D. Freyer G, et al. Among authors: kerger j. Clin Cancer Res. 2002 Jan;8(1):95-102. Clin Cancer Res. 2002. PMID: 11801544 Clinical Trial.

9

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.

Berliere M, Dalenc F, Malingret N, Vindevogel A, Piette P, Roche H, Donnez J, Symann M, Kerger J, Machiels JP. Berliere M, et al. Among authors: kerger j. BMC Cancer. 2008 Feb 21;8:56. doi: 10.1186/1471-2407-8-56. BMC Cancer. 2008. PMID: 18291033 Free PMC article.

10

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

Roy A, Cunningham D, Hawkins R, Sörbye H, Adenis A, Barcelo JR, Lopez-Vivanco G, Adler G, Canon JL, Lofts F, Castanon C, Fonseca E, Rixe O, Aparicio J, Cassinello J, Nicolson M, Mousseau M, Schalhorn A, D'Hondt L, Kerger J, Hossfeld DK, Garcia Giron C, Rodriguez R, Schoffski P, Misset JL. Roy A, et al. Among authors: kerger j. Br J Cancer. 2012 Jul 24;107(3):435-41. doi: 10.1038/bjc.2012.286. Epub 2012 Jul 5. Br J Cancer. 2012. PMID: 22767144 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page